Metformin May Ease Knee Pain in Overweight Osteoarthritis Patients: Randomized Trial Suggests Modest Benefit Medha Baranwal28 April 2025 5:30 AM ISTAustralia: A new randomized clinical trial has demonstrated that metformin, a drug commonly used to manage type 2 diabetes, may significantly reduce...
4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry Farhat Nasim18 April 2025 6:13 PM ISTDelhi: The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain widely used strengths of...
Govt Bans 35 Combination Drugs, See Full List Farhat Nasim16 April 2025 8:36 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug...
Metformin: A Potential Therapy for Periodontal Tissue Repair following periodontitis Dr. Shravani Dali13 April 2025 9:00 PM ISTResearchers have found in a new research that Metformin shows promise in promoting periodontal tissue repair following periodontitis. It is attained...
Prediabetes and CV Risk: Evidence Review in 2025 Dr.Soumya S L11 April 2025 12:30 PM ISTPrediabetes: Potential Cardiovascular (CV) Warning Sign: India has a high prediabetes prevalence (15.3%), nearly equal in urban (15.4%) and rural...
Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
USV Launches Empagliflozin Range Under Xenia Brand Deeksha Bhandari2 April 2025 12:23 PM ISTUSV Pvt. Ltd., a leader in diabetes care, has announced the launch of its Xenia brand range in India, following the patent expiry of Empagliflozin. ...
Lupin Launches Ajaduo M Forte, a Triple Fixed-Dose Combination of Empagliflozin, Linagliptin, and Metformin Extended Release (ER) MDTV Bureau31 March 2025 10:15 AM ISTGlobal pharmaceutical company Lupin Limited has announced the launch of Ajaduo M Forte, a novel triple fixed-dose combination (FDC) therapy for the...
Can Metformin Counteract Antipsychotic-Induced Hyperprolactinemia? New Evidence Emerges Medha Baranwal28 March 2025 8:30 PM ISTTaiwan: A recent meta-analysis of randomized controlled trials has highlighted the potential of metformin in reducing antipsychotic-induced...
USV Launches Xenia Brand Range Following Empagliflozin Patent Expiry Deeksha Bhandari21 March 2025 6:00 PM ISTNew Delhi: Strengthening its leadership in diabetes care, USV Pvt. Ltd. has announced the launch of its Xenia brand range, following...
Addition of Metformin to SGLT2 Inhibitors Lowers Kidney Disease Risk in Diabetes Patients: Study Dr Riya Dave14 March 2025 9:00 AM ISTResearchers have found in a new study that patients receiving a combination of metformin and SGLT2 inhibitors experienced a significant reduction in...
Prediabetes and Associated Risk in Young Adults - Alopecia Areata and Erectile Dysfunction Dr Anshul Agrawal13 March 2025 12:23 PM ISTThe rising prevalence of prediabetes among young adults signals early metabolic dysfunction, significantly increasing the risk of type 2 diabetes...
